Skip to main content
Top
Published in: Advances in Therapy 7/2016

01-07-2016 | Original Research

Effect of Cardiac-Cycle-Synchronized Selective Vagal Stimulation on Heart Rate and Blood Pressure in Rats

Authors: Dennis T. T. Plachta, Josef Zentner, Debora Aguirre, Oscar Cota, Thomas Stieglitz, Mortimer Gierthmuehlen

Published in: Advances in Therapy | Issue 7/2016

Login to get access

Abstract

Introduction

Activation of the baroreflex system through the selective vagal nerve stimulation (sVNS) may become a treatment option for therapy-resistant hypertension, which is a frequently observed problem in the antihypertensive therapy. In previous studies, we used continuous sVNS to lower blood pressure (BP) without major side effects in a rat model. As continuous stimulation is energy consuming and sVNS could be implemented in an antihypertensive stimulator, it was the aim of this study to investigate the efficacy of pulsatile, cardiac-cycle-synchronized sVNS (cssVNS) on the reduction of BP.

Methods

A multichannel cuff electrode was wrapped around the left vagal nerve in six male Wistar rats under Isoflurane anesthesia. BP was recorded in the left carotid artery. An electrocardiogram (ECG) was obtained via subcutaneous needle electrodes. The aortic depressor nerve fibers in the vagal nerve bundle were selectively stimulated with 18 parameter settings within a window of 15–30 ms after the R-peak in the ECG. The stimulation paradigm included every heartbeat, every second heart beat, and every third heart beat. BP and heart rate were initially recorded over 10 min.

Results

Using cssVNS, BP could be significantly reduced over 30 min and maintained at this level. While the highest BP reduction was seen during cssVNS at every heartbeat with minimal bradycardia, less—yet significant—BP reduction was seen during cssVNS at every second or third heartbeat without causing detectable bradycardia.

Conclusion

cssVNS can chronically reduce BP in rats avoiding measurable bradycardic side effects. This energy-efficient technique might allow the implementation of sVNS using an implantable device to permanently lower BP in patients.

Funding

The study was funded by Bundesministerium fur Bildung und Forschung/German Federal Ministry of Education and Research among the call “Individualisierte Medizintechnik” under the grant number FKZ 13GW0120B.
Literature
1.
go back to reference Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117(25):e510–26.CrossRefPubMed Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117(25):e510–26.CrossRefPubMed
2.
go back to reference Persell SD. Prevalence of resistant hypertension in the United States, 2003–2008. Hypertension. 2011;57(6):1076–80.CrossRefPubMed Persell SD. Prevalence of resistant hypertension in the United States, 2003–2008. Hypertension. 2011;57(6):1076–80.CrossRefPubMed
3.
go back to reference Urban D, Ewen S, Ukena C, Linz D, Bohm M, Mahfoud F. Treating resistant hypertension: role of renal denervation. Integr Blood Press Control. 2013;6:119–28.PubMedPubMedCentral Urban D, Ewen S, Ukena C, Linz D, Bohm M, Mahfoud F. Treating resistant hypertension: role of renal denervation. Integr Blood Press Control. 2013;6:119–28.PubMedPubMedCentral
4.
go back to reference Alnima T, de Leeuw PW, Kroon AA. Baroreflex activation therapy for the treatment of drug-resistant hypertension: new developments. Cardiol Res Pract. 2012;2012:587194.PubMedPubMedCentral Alnima T, de Leeuw PW, Kroon AA. Baroreflex activation therapy for the treatment of drug-resistant hypertension: new developments. Cardiol Res Pract. 2012;2012:587194.PubMedPubMedCentral
5.
go back to reference Bakris GL, Townsend RR, Liu M, Cohen SA, D’Agostino R, Flack JM, et al. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3. J Am Coll Cardiol. 2014;64(11):1071–8.CrossRefPubMed Bakris GL, Townsend RR, Liu M, Cohen SA, D’Agostino R, Flack JM, et al. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3. J Am Coll Cardiol. 2014;64(11):1071–8.CrossRefPubMed
6.
go back to reference Bloch MJ, Basile JN. The Rheos Pivotol trial evaluating baroreflex activation therapy fails to meet efficacy and safety end points in resistant hypertension: back to the drawing board. J Clin Hypertens (Greenwich). 2012;14(3):184–6.CrossRef Bloch MJ, Basile JN. The Rheos Pivotol trial evaluating baroreflex activation therapy fails to meet efficacy and safety end points in resistant hypertension: back to the drawing board. J Clin Hypertens (Greenwich). 2012;14(3):184–6.CrossRef
7.
go back to reference Bisognano JD, Bakris G, Nadim MK, Sanchez L, Kroon AA, Schafer J, et al. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. J Am Coll Cardiol. 2011;58(7):765–73.CrossRefPubMed Bisognano JD, Bakris G, Nadim MK, Sanchez L, Kroon AA, Schafer J, et al. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. J Am Coll Cardiol. 2011;58(7):765–73.CrossRefPubMed
8.
go back to reference Durand MT, Mota AL, Barale AR, Castania JA, Fazan R Jr, Salgado HC. Time course of the hemodynamic responses to aortic depressor nerve stimulation in conscious spontaneously hypertensive rats. Braz J Med Biol Res. 2012;45(5):444–9.CrossRefPubMedPubMedCentral Durand MT, Mota AL, Barale AR, Castania JA, Fazan R Jr, Salgado HC. Time course of the hemodynamic responses to aortic depressor nerve stimulation in conscious spontaneously hypertensive rats. Braz J Med Biol Res. 2012;45(5):444–9.CrossRefPubMedPubMedCentral
9.
go back to reference Plachta DT, Gierthmuehlen M, Cota O, Espinosa N, Boeser F, Herrera TC, et al. Blood pressure control with selective vagal nerve stimulation and minimal side effects. J Neural Eng. 2014;11(3):036011.CrossRefPubMed Plachta DT, Gierthmuehlen M, Cota O, Espinosa N, Boeser F, Herrera TC, et al. Blood pressure control with selective vagal nerve stimulation and minimal side effects. J Neural Eng. 2014;11(3):036011.CrossRefPubMed
10.
go back to reference Chapleau MW, Hajduczok G, Abboud FM. Pulsatile activation of baroreceptors causes central facilitation of baroreflex. Am J Physiol. 1989;256(6 Pt 2):H1735–41.PubMed Chapleau MW, Hajduczok G, Abboud FM. Pulsatile activation of baroreceptors causes central facilitation of baroreflex. Am J Physiol. 1989;256(6 Pt 2):H1735–41.PubMed
11.
go back to reference Chapleau MW, Abboud FM. Contrasting effects of static and pulsatile pressure on carotid baroreceptor activity in dogs. Circ Res. 1987;61(5):648–58.CrossRefPubMed Chapleau MW, Abboud FM. Contrasting effects of static and pulsatile pressure on carotid baroreceptor activity in dogs. Circ Res. 1987;61(5):648–58.CrossRefPubMed
12.
go back to reference Gierthmuehlen M, Plachta DT. Effect of selective vagal nerve stimulation on blood pressure, heart rate and respiratory rate in rats under metoprolol medication. Hypertens Res. 2016;39(2):79–87. doi:10.1038/hr.2015.122.CrossRef Gierthmuehlen M, Plachta DT. Effect of selective vagal nerve stimulation on blood pressure, heart rate and respiratory rate in rats under metoprolol medication. Hypertens Res. 2016;39(2):79–87. doi:10.​1038/​hr.​2015.​122.CrossRef
13.
go back to reference Waynforth HB, Flecknell PA. Experimental and Surgical Technique in the Rat. 2nd ed. Amsterdam: Elsevier; 1992. Waynforth HB, Flecknell PA. Experimental and Surgical Technique in the Rat. 2nd ed. Amsterdam: Elsevier; 1992.
14.
go back to reference Stieglitz T, Beutel H, Schuettler M, Meyer J-U. Micromachined, polyimide-based devices for flexible neural interfaces. Biomed Microdevices. 2000;2(4):283–94.CrossRef Stieglitz T, Beutel H, Schuettler M, Meyer J-U. Micromachined, polyimide-based devices for flexible neural interfaces. Biomed Microdevices. 2000;2(4):283–94.CrossRef
15.
go back to reference Zariffa J, Popovic MR. Influence of the number and location of recording contacts on the selectivity of a nerve cuff electrode. IEEE Trans Bio-Med Eng. 2009;17(5):420–7. Zariffa J, Popovic MR. Influence of the number and location of recording contacts on the selectivity of a nerve cuff electrode. IEEE Trans Bio-Med Eng. 2009;17(5):420–7.
16.
go back to reference Plachta DT, Espinosa N, Gierthmuehlen M, Cota O, Herrera TC, Stieglitz T. Detection of baroreceptor activity in rat vagal nerve recording using a multi-channel cuff-electrode and real-time coherent averaging. Conf Proc IEEE Eng Med Biol Soc. 2012;2012:3416–9.PubMed Plachta DT, Espinosa N, Gierthmuehlen M, Cota O, Herrera TC, Stieglitz T. Detection of baroreceptor activity in rat vagal nerve recording using a multi-channel cuff-electrode and real-time coherent averaging. Conf Proc IEEE Eng Med Biol Soc. 2012;2012:3416–9.PubMed
17.
go back to reference Burnier M, Wuerzner G, Struijker-Boudier H, Urquhart J. Measuring, analyzing, and managing drug adherence in resistant hypertension. Hypertension. 2013;62(2):218–25.CrossRefPubMed Burnier M, Wuerzner G, Struijker-Boudier H, Urquhart J. Measuring, analyzing, and managing drug adherence in resistant hypertension. Hypertension. 2013;62(2):218–25.CrossRefPubMed
18.
go back to reference Persell SD, Denecke-Dattalo TA, Dunham DP, Baker DW. Patient-directed intervention versus clinician reminders alone to improve aspirin use in diabetes: a cluster randomized trial. Jt Comm J Qual Patient Saf. 2008;34(2):98–105.PubMed Persell SD, Denecke-Dattalo TA, Dunham DP, Baker DW. Patient-directed intervention versus clinician reminders alone to improve aspirin use in diabetes: a cluster randomized trial. Jt Comm J Qual Patient Saf. 2008;34(2):98–105.PubMed
19.
go back to reference Bilgutay A, Lillehei C. Treatment of hypertension with an implantable electronic device. JAMA. 1965;191:649–53.CrossRefPubMed Bilgutay A, Lillehei C. Treatment of hypertension with an implantable electronic device. JAMA. 1965;191:649–53.CrossRefPubMed
20.
go back to reference Bilgutay AM, Lillehei CW. Surgical treatment of hypertension with reference to baropacing. Am J Cardiol. 1966;17(5):663–7.CrossRefPubMed Bilgutay AM, Lillehei CW. Surgical treatment of hypertension with reference to baropacing. Am J Cardiol. 1966;17(5):663–7.CrossRefPubMed
21.
go back to reference Neistadt A, Schwartz S. Effects of electrical stimulation of the carotid sinus nerve in reversal of experimentally induced hypertension. Surgery. 1967;61:923–31.PubMed Neistadt A, Schwartz S. Effects of electrical stimulation of the carotid sinus nerve in reversal of experimentally induced hypertension. Surgery. 1967;61:923–31.PubMed
22.
go back to reference Ramani R. Vagus Nerve Stimulation Therapy for Seizures. J Neurosurg Anesthesiol. 2008;20(1):29–35.CrossRefPubMed Ramani R. Vagus Nerve Stimulation Therapy for Seizures. J Neurosurg Anesthesiol. 2008;20(1):29–35.CrossRefPubMed
23.
24.
go back to reference Rogers RF, Paton JF, Schwaber JS. NTS neuronal responses to arterial pressure and pressure changes in the rat. Am J Physiol. 1993;265(6 Pt 2):R1355–68.PubMed Rogers RF, Paton JF, Schwaber JS. NTS neuronal responses to arterial pressure and pressure changes in the rat. Am J Physiol. 1993;265(6 Pt 2):R1355–68.PubMed
25.
go back to reference Zhang J, Mifflin SW. Responses of aortic depressor nerve-evoked neurones in rat nucleus of the solitary tract to changes in blood pressure. J Physiol. 2000;529(Pt 2):431–43.CrossRefPubMedPubMedCentral Zhang J, Mifflin SW. Responses of aortic depressor nerve-evoked neurones in rat nucleus of the solitary tract to changes in blood pressure. J Physiol. 2000;529(Pt 2):431–43.CrossRefPubMedPubMedCentral
26.
go back to reference Tanaka K, Yada I. NTS neuronal response to conversion from pulsatile to nonpulsatile pressure in isolated carotid sinus baroreceptors. Artif Organs. 2003;27(9):833–9.CrossRefPubMed Tanaka K, Yada I. NTS neuronal response to conversion from pulsatile to nonpulsatile pressure in isolated carotid sinus baroreceptors. Artif Organs. 2003;27(9):833–9.CrossRefPubMed
Metadata
Title
Effect of Cardiac-Cycle-Synchronized Selective Vagal Stimulation on Heart Rate and Blood Pressure in Rats
Authors
Dennis T. T. Plachta
Josef Zentner
Debora Aguirre
Oscar Cota
Thomas Stieglitz
Mortimer Gierthmuehlen
Publication date
01-07-2016
Publisher
Springer Healthcare
Published in
Advances in Therapy / Issue 7/2016
Print ISSN: 0741-238X
Electronic ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-016-0348-z

Other articles of this Issue 7/2016

Advances in Therapy 7/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.